Effects of CB1 antagonist on the control of metabolic functions in obese type 2 diabetic patients - ScienceDirect
Cannabinoid Receptor Signaling | Cannabinoid Receptor Inhibitor Review
Cannabinoid CB1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders | Arteriosclerosis, Thrombosis, and Vascular Biology
Peripherally selective CB1 receptor antagonists. | Download Scientific Diagram
Molecules | Free Full-Text | CB1 Cannabinoid Receptor Signaling and Biased Signaling
Cannabinoid receptor antagonist - Wikipedia
Coordinated Regulation of CB1 Cannabinoid Receptors and Anandamide Metabolism Stabilizes Network Activity during Homeostatic Downscaling | eNeuro
Kinetics of human cannabinoid 1 (CB1) receptor antagonists: Structure-kinetics relationships (SKR) and implications for insurmountable antagonism - ScienceDirect
CB1-Antagonist hilft beim metabolischen Syndrom – Rosenfluh.ch
CB1 antagonist AM251 | 183232-66-8
Role of endocannabinoid CB1 receptors in Streptozotocin-induced uninephrectomised Wistar rats in diabetic nephropathy | Beni-Suef University Journal of Basic and Applied Sciences | Full Text
A: Schematic overview summarizing the metabolic effects of CNS-CB1... | Download Scientific Diagram
Inversago Pharma startet klinische Studien und beginnt mit einer Phase-1-Studie mit INV-101, dem führenden peripheren CB1-Blocker des Unternehmens | Business Wire
Personalized medicine can pave the way for the safe use of CB1 receptor antagonists: Trends in Pharmacological Sciences
The therapeutic potential of second and third generation CB1R antagonists - ScienceDirect
Cannabinoid receptor antagonist - Wikipedia
Cannabinoid Receptor Antagonist | Encyclopedia MDPI
Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist | ACS Pharmacology & Translational Science
Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice | International Journal of Obesity
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders: Trends in Pharmacological Sciences
CB1 antagonist 1 | Cannabinoid Receptor Antagonist | MedChemExpress
